Return to Article Details CONSTRUCT THE MODEL OF COST– EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS STANDARD THERAPY IN THE TREATMENT OF MULTIPLE MYELOMA IN VIETNAM Download Download PDF